Saffron (Crocus sativus L.) as a Promising Complementary Treatment for Depression: A Review of Basic and Clinical Studies

Ali, Samira

doi:10.22077/jsr.2025.8449.1250

Document Type : Review Article

Author

Samira Ali

PhD graduate in Crop Physiology from the College of Agriculture and Natural Resources, University of Tehran, Tehran, Iran and Master's student in Clinical Psychology at the Non-Profit Naser Khosrow Institute in Saveh, Saveh, Iran.

https://doi.org/10.22077/jsr.2025.8449.1250

Abstract

Introduction: Depression is a mood disorder that has profound effects on both mental and physical health, leading to decreased quality of life, cognitive issues, and increased susceptibility to various diseases. Current treatments mainly depend on pharmaceutical medications, which can have associated side effects. In this context, the use of natural remedies, including medicinal plants such as saffron, has gained attention for their potential in alleviating depression symptoms. Saffron, known for its calming, anti-anxiety, and anti-inflammatory properties, has emerged as a promising natural treatment option for depression.

Materials and Methods: A comprehensive literature search was conducted in the PubMed and Google Scholar databases for studies published between 2019 and 2024. The search terms included "saffron and depression," "crocin and depression," "saffronal and depression," and "saffron compounds and mood disorders." Studies were included if they focused on the effects of saffron and its compounds on depression, with full-text access available. Studies that only contained abstracts or were written in languages other than English were excluded.

Results and Discussion: The reviewed studies indicate that saffron and its active compounds, particularly crocin and safranal, exhibit significant antidepressant effects. These effects are attributed to the modulation of neurotransmitter systems such as serotonin, dopamine, norepinephrine, and GABA, as well as the reduction of inflammation and the increase in antioxidant activity within the brain. Moreover, saffron has been shown to positively influence the brain-derived neurotrophic factor (BDNF) and neurogenesis, further contributing to the reduction of depression symptoms. In preclinical animal models, saffron’s antidepressant effects were demonstrated through behavioral tests such as the forced swimming test (FST) and tail suspension test (TST), where saffron-treated animals showed significant improvements in depressive behaviors. The antidepressant effects of saffron can be attributed to several neurobiological mechanisms. Crocin and safranal, two of saffron’s primary bioactive compounds, act by inhibiting the reuptake of dopamine, norepinephrine, and serotonin, thereby increasing their availability in the brain. Additionally, saffron has antioxidant properties that protect neurons from oxidative damage, and it regulates the hypothalamic-pituitary-adrenal (HPA) axis, which plays a key role in stress and mood regulation. Furthermore, saffron’s impact on neuroinflammation and its ability to modulate neurotransmitter systems like GABA and glutamate contribute to its antidepressant effects. These mechanisms collectively help improve neuronal plasticity and restore mood balance, making saffron a promising adjunctive treatment for depression.

Conclusion: Saffron appears to be a promising natural remedy for alleviating depression, particularly in cases where conventional treatments have been insufficient. Its active compounds, crocin and safranal, exert antidepressant, anti-inflammatory, antioxidant, and neuroprotective effects, making saffron a viable alternative or complementary treatment to traditional pharmacological interventions. However, further clinical studies with larger sample sizes and long-term follow-up are needed to confirm the efficacy and safety of saffron in treating depression in clinical settings.

Keywords

References

Ahmad, S., A., Azhar, A., Tikmani, P., Rafique, H., Khan, A., Mesiya, H. &Saeed, H. (2022) .A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients.Heliyon,8, 1-8.

Ahmadpanah, M, Ramezanshams, F., Ghaleiha, A ., Akhondzadeh, S ., Bahmani, DS. & Brand, S. (2022). Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders – a double-blind, randomized intervention study. Psychiatry research, 1-27.

Allen, L. &Dwivedi, Y. (2020). MicroRNA mediators of early life stress vulnerability todepression and suicidal behavior. Molecular Psychiatry, 25:308–320.

Arnone, D., McKie, S., Elliott, R., Juhasz, G., Thomas, E. J. & Downey, D. (2013). State-dependent changes in hippocampal grey matter in depression. Molecular Psychiatry,18,1265–1272.

Alsanie,WF., Alamri,AS., Abdulaziz, O., Salih,MM., Alamri, A., Asdaq,SMB. &Alhomrani, MH. (2022).Molecules,27,1-12.

Amin, F., Ibrahim, M.A.A., Rizwan-ul-Hasan, S., Khaliq, S., Gabr, G.A., Muhammad, Khan, A., Sidhom, P.A., Tikmani, P., Shawky, A.M.(2022). Interactions of Apigenin and Safranal with the 5HT1A and 5HT2A Receptors and Behavioral Effects in Depression and Anxiety: A Molecular Docking, Lipid-Mediated Molecular Dynamics, and In Vivo Analysis. Molecules, 27, 1-24.

Beck, AT., Ward, CH., Mendelson, M., Mock, J. &Erbaugh, J. (1961) An inventory for measuring depression. Archives of GeneralPsychiatry ,4, 561-571.

Binte Ibrahim, S. (2024). A thesis submitted to the School of Pharmacy in partial fulfillment of the requirements. for the degree of Bachelor of Pharmacy , School of Pharmacy Brac University April 2024.

Cardone, L., Castronuovo, D., Perniola, M., Cicco, N., &Candido, V. (2020). Saffron (Crocus sativus L.), the king of spices: An overview. Scientia Horticulturae,272.

Cheng, Y., Rodriguiz, R. M.,Murthy, S. R. K., SenatoroV, V., ThouEnnon, E., Cawley, N. X., et al. (2015). Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone. Molecular Psychiatry, 20, 744–754.

Dahchour,A. (2021). The effects of saffron (Crocus sativus L.) and its components on depression: from basic to clinical studies. Moroccan Journal of Biology,18: 10-33.

Dai, L., Chen, L., & Wang, W. (2020).Safety and Efficacy of Saffron (Crocus sativus L.) for Treating Mild to Moderate Depression.The Journal of Nervous and Mental Disease, 208(4), 269–276.

Dean, J. R., &Keshavan, M. S. (2017). The neurobiology of depression: An integrated view. Asian Journal of Psychiatry, 27, 101–111.

Delam, H., Keshtkaran, Z., Shokrpour, N .Eidi, A & Bazrafshan, MR. (2023). The effect of Crocus sativusL. (saffron) herbal tea on happiness in postmenopausal women: a randomized controlled trial BMC Complementary Medicine and Therapies, 23,1-9.

Du, Y., Wang, Y-L., Chen, L., Li, Q-E.& Cheng, Y. (2023). Anti-depressant-like effects of rannasangpei and its active ingredient crocin-1 on chronic unpredictable mild stress mice. Frontiers in Pharmacology,14,1-10.

Fathinezhad, Z., Sewell, R.D.E. &Lorigooini, Z. (2019).Rafieian-Kopaei, M. Depression and treatment with effective herbs.Current Pharmaceutical Design, 25(6), 738-745.

Ghorbani, M., Tabatabaeichehr, M., Bagheri, M., Salari, E., &Nazari, S. (2019). Effect of saffron on happiness of postmenopausal women: a clinical randomized trial. The Iranian Journal of Obstetrics, Gynecology and Infertility, 22(4), 11-17.

Hamilton, M. (1967) Development of arating scale for primary depressive illness.The British Journal of Social & ClinicalPsychology 6(4): 278–296.

Hosseini, A., Razavi, B. M., &Hosseinzadeh, H. (2018). Saffron (Crocus sativus) petal as a new pharmacological target: a review. Iranian journal of basic medical sciences, 21(11), 1091–1099. [in Persian].

Hosseinzadeh, H., Karimi, G., & Niapour, M. (2004). Comparative antidepressant effects of saffron extracts and its active components, crocin and safranal, in mice. Journal of Medicinal Plants Quarterly, 3(4), 48-58. [in Persian].

Gururajan, A., Reif, A., Cryan, J.F.& Slattery, D.A.(2019). The future ofrodent models in depression research.Nature Reviews Neuroscience,20(11), 686-701.

Jackson, PA., Forster, J., Khan, J., Pouchieu , C., Dubreuil, S., Gaudout, D., Moras, B, Pourtau, L, Joffre, F,.Vaysse, C., Bertrand, K., Abrous, H., Vauzour, D., Brossaud, J., Corcuff, JB., Capuron, L. & Kennedy, DO. (2021). Effects of Saffron Extract Supplementation on Mood, Well-Being, and Response to a Psychosocial Stressor in Healthy Adults: A Randomized, Double-Blind, Parallel Group, Clinical Trial.Front. Nutrition, 7,1-13.

Jantan, I.(2015). The evolving role of natural products from the tropicalrainforests as a replenishable source of new drug leads. Drug Discovery and Development, 3-38.

Jiang, C. Y., Qin, X. Y., Yuan, M. M., Lu, G. J., and Cheng, Y. (2018). 2,3,5,4’-Tetrahydroxystilbene-2-O-beta-D-glucoside reverses stress-induced depression viainflammatory and oxidative stress pathways. Oxidative Medicine and Cellular Longevity,1-13.

Khaksarian, M., Behzadifar, M., Behzadifar, M., Alipour, M., Jahanpanah, F, Re, T.S., Firenzuoli, F., Zerbetto, R.&Bragazzi,N.L. (2019) .The efficacy of Crocus sativus (Saffron) versus placebo and Fluoxetine in treating depression: A systematic review andmeta-analysis.psychology research and behavior management,12: 297–305.

Khan, A., Muhamad, NA., Ismail, H., Nasir, A., Khan Khalil, A.A., Anwar, Y., Khan, Z., Ali, A., Mat Taha, R ., Al-Shara., B., Latif, S., Mirza, B., AbdalJalilFadladdin, Y., Abu Zeid, IM & Al-Thobaiti, SA. (2020). Potential Nutraceutical Benefits of In Vivo Grown Sa_ron (Crocus sativus L.) As Analgesic, Anti-inflammatory, Anticoagulant, and Antidepressant in Mice, Plants, 9,1-17.

Lautenschlager, M.; Sendker, J.; Huwel, S.; Galla, H.J.; Brandt, S.; Dufer, M.; Riehemann, K.; Hensel, A.(2015) Intestinal formation of trans-crocetin from sa_ron extract (Crocus sativus L.) and in vitro permeation through intestinal and blood brain barrier.Phytomedicine, 22, 36–44.

LeMoult, J. &Gotlib, I.H. (2019). Depression: A cognitive perspective. Clinical Psychology Review,69,51-66.

Li, Z., Ruan, M., Chen, J. &Fang, Y. (2021). Major depressive disorder: Advances inneuroscience research and translational applications. Neuroscience Bulletin, 37, 863–880.

Lopresti, AL., Smith, SJ., Hood, SD. & Drummond, PD. (2019). Efficacy of a standardised saffron extract (affron) as an add-on to antidepressant medication for the treatment of persistent depressive symptoms in adults: A randomised, double-blind, placebo-controlled study. Journal of Psychopharmacology,1-13.

Lu, L., Wu, D., Wang, K., Tang, J. & Chen, G. (2020).Beneficial Effects of Crocin against Depression via PituitaryAdenylateCyclase-Activating Polypeptide.BioMed research international, 1-10.

Marx, W., Lane, M., Rocks, T., Ruusunen, A., Loughman, A., Lopresti, A., Marshall, S., Berk, M., Jacka, F. & Dean, O.M. (2019). Effect of saffron supplementation on symptoms of depression and anxiety: A systematic review and meta-analysis. Nutrition Reviews, 77(8), 557-571.

McEwen, B. S. (2000). The neurobiology of stress: From serendipity to clinicalrelevance. Brain Research.886,172–189.

Midaoui, A. E., Ghzaiel, I., Vervandier‐Fasseur, D., Ksila, M., Zarrouk, A., Nury, T., Khallouki, F., Hessni, A. E., Ibrahimi, S. O., Latruffe, N., Couture, R., Kharoubı, O., Brahmi, F., Hammami, S., Masmoudi-Kouki, O., Hammami, M. A., Ghrairi, T., Véjux, A., & Lizard, G. (2022). Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases. Nutrients, 14(3): 597.

Milajerdi, A., Shirzadi, E., Jazayeri, S., Akhundzadeh, S., Hashemzadeh, N., Jazayeri, A ., Derakhshan., J.,Raiti, A., Mahmoudi, M. 2015. The effect of hydroalcoholic extract of saffron (L. sativus Crocus) in the treatment of depression - mild anxiety Combined mean in patients with type 2 diabetes: a three-blind randomized clinical trial.Journal of Nutritional Sciences and Food Industries of Iran, 3: 11-20.

Monchaux De Oliveira, C., Pourtau, L., Vancassel, S., Pouchieu, C., Capuron, L., Gaudout, D. &Castanon, N. (201).Saffron Extract-Induced Improvement of Depressive-Like Behavior in Mice Is Associated with Modulation of Monoaminergic Neurotransmission.Nutrients,13, 1-17.

Monchaux De Oliveira, C.; De Smedt-Peyrusse, V.; Morael, J.; Vancassel, S.; Capuron, L.; Gaudout, D.; Pourtau, L.; Castanon, N. (2021). Prevention of Stress-Induced Depressive-like Behavior by Saffron Extract Is Associated with Modulation of Kynurenine Pathway and Monoamine Neurotransmission. Pharmaceutics, 13,1-24.

Mzabri, İ., Addi, M., &Berrichi, A. (2019).Traditional and modern uses of saffron (Crocus sativus).Cosmetics, 6(4): 1-11.

Norbala, A. A., Tahamasipur, N., Akhundzadah, Sh., Khānī, M., & Jamshīdī, A. H. (2004). Effect of saffron (Crocus sativus L.) in the treatment of mild to moderate depression: A randomized, double-blind, placebo-controlled clinical trial. Journal of Medicinal Plants Quarterly, 10, 31-37.

Noori, T., Sureda, A., Sobarzo-Sanchez, E &Shirooie, S.(2022). The Role of Natural Products in Treatment of Depressive Disorder.Current Neuropharmacology, 20, 929-949. [in Persian].

Orio, L., Alen, F., Ballesta, A., Martin, R. & Gomez de Heras, R) .2020(.Antianhedonic and Antidepressant E_ects of Afron, a Standardized Sa_ron (Crocus Sativus L.) Extract. Molecules,1-14.

Peng, S., Li, W., Lv, L., Zhang, Z., and Zhan, X. (2018).BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression.Discover Medicine, 26,127–136.

Philpotts, R., Gillan, N., Barrow, M., &Seidler, K. (2023). Stress-induced alterations in hippocampal BDNF in the pathophysiology of major depressive disorder and the antidepressant effect of saffron. Journal of Affective Disorders Reports, 14:1-13.

Porsolt, RD., Le Pichon, M. &Jalfre, M. (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature, 266, 730–732.

Sahraian, A., Jelodar, S., Javid, Z., Mowla, A. &Ahmadzadeh, L. (2016). Study the effects of saffron on depression and lipid profiles: A double blind comparative study. Asian Journal of Psychiatry, 22:174-176.

Shafiee, M., Arekhi, S., Omranzadeh, A. &Sahebkar, A. (2018).Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. Journal of Affective Disorders, 227,330-337. [in Persian].

Siddiqui, S. A., Redha, A. A., Snoeck, E. R., Singh, S., Simal-Gándara, J., Ibrahim, S. A., &Jafari, S. M. (2022). Anti-Depressant properties of crocin molecules in saffron.Molecules, 27(7): 1-27.

Song, Y., Wang, Y., Zheng, Y., Liu, T., & Zhang, C. (2021).Crocins: A comprehensive review of structural characteristics, pharmacokinetics and therapeutic effects. Fitoterapia, 153, 1-10.

Sousa, N.; Cerqueira, J.J.; Almeida, O.F. (2008).Corticosteroid receptors and neuroplasticity.Brain Research Reviews, 561–570.

Steru, L., Chermat ,R., Thierry, B. & Simon P.(1985) The tail suspension test: A new method for screening antidepressants inmice. Psychopharmacology, 85(3), 367–370.

Sumiyarini, R. & Diaz, K. (2023). The use of saffron in depression among nursing students in Indonesia: A quasi-experimental study. Journal of Holistic Nursing Science,1,14-21.

Tao,W., Ruan,J., Wu,R., Zhao, M ., Zhao,T., Qi,M., S Y Yau,S., Yao,G., Zhang, H., Hu,Y. & Chen,G. (2023). A natural carotenoid crocin exerts antidepressant action by promoting adult hippocampal neurogenesis through Wnt/β-catenin signaling. Journal of Advanced Research, 43, 219–231.

Tian, H., Hu, Z., Xu, J., & Wang, C. (2022).The molecular pathophysiology of depression and the new therapeutics.MedComm, 3,1-36.

Vankar, P. (2024). Major depressive episode U.S. adults by age and gender 2022.Statista.https://www.statista.com/statistics/252312/major-depressive-episode-among-us-adults-by-age-and-gender

Wang, Y., Zhou, S., Song, X., Ding, S., Wang, B., Wen, J .& Chen, C. (2022).Study on Antidepressant Effect and Mechanism of Crocin Mediated by the mTOR Signaling Pathway,Neurochemical Research, 47, 3126-3136.

Wauquier, F., Boutin-Wittrant, L., Pourtau, L., Gaudout, D., Moras, B., Vignault, A., Monchaux De Oliveira, C., Gabaston,J., Vaysse, C. & Bertrand, K. (2022). Circulating Human SerumMetabolites Derived from the Intake of a Saffron Extract (Safr’InsideTM) Protect Neurons from Oxidative Stress: Consideration for Depressive Disorders. Nutrients, 14,1-15.